Molecular characterization of HCMV-specific immune responses: Parallels between CD8+ T cells, CD4+ T cells, and NK cells

European Journal of Immunology

Volumn 45, Issue 9, 2015, Pages 2433-2445

  Vieira Braga, Felipe A ^a   Hertoghs, Kirsten M L ^a   van Lier, René A W ^a   van Gisbergen, Klaas P J M ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

CD45RA+ CD8+ effector T cell; CD4+ T cell; HCMV; Metabolism; NK cell; Tissue distribution

Indexed keywords

GAMMA INTERFERON; GRANZYME B; CD27 ANTIGEN; CD28 ANTIGEN; GRANZYME;

CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL DIFFERENTIATION; CELL FUNCTION; CELL METABOLISM; CONTROLLED STUDY; CYTOTOXICITY; EFFECTOR CELL; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE SUBPOPULATION; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; REVIEW; TISSUE DISTRIBUTION; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; HOST PATHOGEN INTERACTION; IMMUNOLOGY; INNATE IMMUNITY; LYMPHOCYTE ACTIVATION; PATHOLOGY; SIGNAL TRANSDUCTION; VIROLOGY;

ANTIGENS, CD27; ANTIGENS, CD28; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; GENE EXPRESSION REGULATION; GRANZYMES; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNITY, INNATE; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC;

EID: 84940958422     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201545495     Document Type: Review

References (129)

1. Wherry, E. J. and Ahmed, R., Memory CD8 T-cell differentiation during viral infection. J. Virol. 2004. 78: 5535-5545.
2. van Lier, R. A., ten Berge, I. J. and Gamadia, L.E., Human CD8(+) T-cell differentiation in response to viruses. Nat. Rev. Immunol. 2003. 3: 931-939.
3. Farber, D. L., Yudanin, N. A. and Restifo, N. P., Human memory T cells: generation, compartmentalization and homeostasis. Nat. Rev. Immunol. 2014. 14: 24-35.
4. Petersen, J. L., Morris, C. R. and Solheim, J. C., Virus evasion of MHC class I molecule presentation. J. Immunol. 2003. 171: 4473-4478.
5. Ploegh, H. L., Viral strategies of immune evasion. Science 1998. 280: 248-253.
6. Huard, B. and Fruh, K., A role for MHC class I down-regulation in NK cell lysis of herpes virus-infected cells. Eur. J. Immunol. 2000. 30: 509-515.
7. Thiery, J., Keefe, D., Boulant, S., Boucrot, E., Walch, M., Martinvalet, D., Goping, I. S. et al., Perforin pores in the endosomal membrane trigger the release of endocytosed granzyme B into the cytosol of target cells. Nat. Immunol. 2011. 12: 770-777.
8. Sinclair, J. and Sissons, P., Latency and reactivation of human cytomegalovirus. J. Gen. Virol. 2006. 87: 1763-1779.
9. Ludwig, A. and Hengel, H., Epidemiological impact and disease burden of congenital cytomegalovirus infection in Europe. Euro. Surveill 2009. 14: 26-32.
10. Babic, M., Krmpotic, A. and Jonjic, S., All is fair in virus-host interactions: NK cells and cytomegalovirus. Trends Mol. Med. 2011. 17: 677-685.
11. Rentenaar, R. J., Gamadia, L. E., van, D. N., van Diepen, F. N., Boom, R., Weel, J. F., Wertheim-van Dillen, P. M. et al., Development of virus-specific CD4(+) T cells during primary cytomegalovirus infection. J. Clin. Invest. 2000. 105: 541-548.
12. Kuijpers, T. W., Vossen, M. T., Gent, M. R., Davin, J. C., Roos, M. T., Wertheim-van Dillen, P. M., Weel, J. F. et al., Frequencies of circulating cytolytic, CD45RA+CD27-, CD8+ T lymphocytes depend on infection with CMV. J. Immunol. 2003. 170: 4342-4348.
13. Mackus, W. J., Frakking, F. N., Grummels, A., Gamadia, L. E., de Bree, G. J., Hamann, D., van Lier, R. A. et al., Expansion of CMV-specific CD8+CD45RA+CD27-T cells in B-cell chronic lymphocytic leukemia. Blood 2003. 102: 1057-1063.
14. Kuijpers, T. W., Baars, P. A., Dantin, C., van den Burg, M., van Lier, R. A. and Roosnek, E., Human NK cells can control CMV infection in the absence of T cells. Blood 2008. 112: 914-915.
15. Enblad, G., Hagberg, H., Erlanson, M., Lundin, J., MacDonald, A. P., Repp, R., Schetelig, J. et al., A pilot study of alemtuzumab (anti-CD52 monoclonal antibody) therapy for patients with relapsed or chemotherapy-refractory peripheral T-cell lymphomas. Blood 2004. 103: 2920-2924.
16. Lundin, J., Kimby, E., Bjorkholm, M., Broliden, P. A., Celsing, F., Hjalmar, V., Mollgard, L. et al., Phase II trial of subcutaneous anti-CD52 monoclonal antibody alemtuzumab (Campath-1H) as first-line treatment for patients with B-cell chronic lymphocytic leukemia (B-CLL). Blood 2002. 100: 768-773.
17. Chan, G., Bivins-Smith, E. R., Smith, M. S., Smith, P. M. and Yurochko, A. D., Transcriptome analysis reveals human cytomegalovirus reprograms monocyte differentiation toward an M1 macrophage. J. Immunol. 2008. 181, 698-711.
18. Smith, M. S., Bentz, G. L., Alexander, J. S. and Yurochko, A. D., Human cytomegalovirus induces monocyte differentiation and migration as a strategy for dissemination and persistence. J. Virol. 2004. 78: 4444-4453.
19. Klein, M., Schoppel, K., Amvrossiadis, N. and Mach, M., Strain-specific neutralization of human cytomegalovirus isolates by human sera. J. Virol. 1999. 73: 878-886.
20. Schoppel, K., Schmidt, C., Einsele, H., Hebart, H. and Mach, M., Kinetics of the antibody response against human cytomegalovirus-specific proteins in allogeneic bone marrow transplant recipients. J. Infect. Dis. 1998. 178: 1233-1243.
21. Khairallah, C., Netzer, S., Villacreces, A., Juzan, M., Rousseau, B., Dulanto, S., Giese, A. et al., Gammadelta T cells confer protection against murine cytomegalovirus (MCMV). PLoS. Pathog. 2015. 11: e1004702.
22. Couzi, L., Pitard, V., Moreau, J. F., Merville, P. and Dechanet-Merville, J., Direct and indirect effects of cytomegalovirus-induced gammadelta T cells after kidney transplantation. Front Immunol. 2015. 6: 3.
23. Sell, S., Dietz, M., Schneider, A., Holtappels, R., Mach, M. and Winkler, T. H., Control of murine cytomegalovirus infection by gammadelta T cells. PLoS. Pathog. 2015. 11: e1004481.
24. Mahnke, Y. D., Brodie, T. M., Sallusto, F., Roederer, M. and Lugli, E., The who's who of T-cell differentiation: human memory T-cell subsets. Eur. J. Immunol. 2013. 43: 2797-2809.
25. ten Berge, I. J., Gamadia, L. E., Remmerswaal, E. B., Surachno, S., Weel, J. F., Toebes, M., Schumacher, T. N. et al., Differentiation of CMV-specific CD8(POS) T lymphocytes in primary CMV infection after renal transplantation. Transplant. Proc. 2001. 33: 3630.
26. Gamadia, L. E., Rentenaar, R. J., Baars, P. A., Remmerswaal, E. B., Surachno, S., Weel, J. F., Toebes, M. et al., Differentiation of cytomegalovirus-specific CD8(+) T cells in healthy and immunosuppressed virus carriers. Blood 2001. 98: 754-761.
27. Jackson, S. E., Mason, G. M., Okecha, G., Sissons, J. G. and Wills, M. R., Diverse specificities, phenotypes, and antiviral activities of cytomegalovirus-specific CD8+ T cells. J. Virol. 2014. 88: 10894-10908.
28. van de Berg, P. J., van, S. A., ten Berge, I. J. and van Lier, R. A., A fingerprint left by cytomegalovirus infection in the human T cell compartment. J. Clin. Virol. 2008. 41: 213-217.
29. Weekes, M. P., Carmichael, A. J., Wills, M. R., Mynard, K. and Sissons, J. G., Human CD28-CD8+ T cells contain greatly expanded functional virus-specific memory CTL clones. J. Immunol. 1999. 162, 7569-7577.
30. Wallace, D. L., Masters, J. E., De Lara, C. M., Henson, S. M., Worth, A., Zhang, Y., Kumar, S. R. et al., Human cytomegalovirus-specific CD8(+) T-cell expansions contain long-lived cells that retain functional capacity in both young and elderly subjects. Immunology 2011. 132: 27-38.
31. Rentenaar, R. J., Gamadia, L. E., van der Hoek, N., van Diepen, F. N., Wertheim-van Dillen, P. M., Weel, J. F., Surachno, S. et al., CD8(POS) lymphocyte dynamics in primary CMV infection. Transplant. Proc. 2001. 33: 1867-1869.
32. van Leeuwen, E. M., Koning, J. J., Remmerswaal, E. B., van, B. D., van Lier, R. A. and ten Berge, I. J., Differential usage of cellular niches by cytomegalovirus versus EBV- and influenza virus-specific CD8+ T cells. J. Immunol. 2006. 177: 4998-5005.
33. Simmons, R., Sharp, C., Sims, S., Kloverpris, H., Goulder, P., Simmonds, P., Bowness, P. et al., High frequency, sustained T cell responses to PARV4 suggest viral persistence in vivo. J. Infect. Dis. 2011. 203: 1378-1387.
34. Swanson, P. A., Hofstetter, A. R., Wilson, J. J. and Lukacher, A. E., Cutting edge: shift in antigen dependence by an antiviral MHC class Ib-restricted CD8 T cell response during persistent viral infection. J. Immunol. 2009. 182: 5198-5202.
35. Kaech, S. M., Tan, J. T., Wherry, E. J., Konieczny, B. T., Surh, C. D. and Ahmed, R., Selective expression of the interleukin 7 receptor identifies effector CD8 T cells that give rise to long-lived memory cells. Nat. Immunol. 2003. 4: 1191-1198.
36. Antia, R., Bergstrom, C. T., Pilyugin, S. S., Kaech, S. M. and Ahmed, R., Models of CD8+ responses: 1. What is the antigen-independent proliferation program. J. Theor. Biol. 2003. 221: 585-598.
37. Hertoghs, K. M., Moerland, P. D., van, S. A., Remmerswaal, E. B., Yong, S. L., van de Berg, P. J., van Ham, S. M. et al., Molecular profiling of cytomegalovirus-induced human CD8+ T cell differentiation. J. Clin. Invest. 2010. 120: 4077-4090.
38. van Leeuwen, E. M., de Bree, G. J., Remmerswaal, E. B., Yong, S. L., Tesselaar, K., ten Berge, I. J. and van Lier, R. A., IL-7 receptor alpha chain expression distinguishes functional subsets of virus-specific human CD8+ T cells. Blood 2005. 106: 2091-2098.
39. Remmerswaal, E. B., Havenith, S. H., Idu, M. M., van Leeuwen, E. M., van Donselaar, K. A., Ten, B. A., Bom-Baylon, N. et al., Human virus-specific effector-type T cells accumulate in blood but not in lymph nodes. Blood 2012. 119: 1702-1712.
40. Quinn, M., Turula, H., Tandon, M., Deslouches, B., Moghbeli, T. and Snyder, C. M., Memory T cells specific for murine cytomegalovirus re-emerge after multiple challenges and recapitulate immunity in various adoptive transfer scenarios. J. Immunol. 2015. 194: 1726-1736.
41. Snyder, C. M., Cho, K. S., Bonnett, E. L., van, D. S., Shellam, G. R. and Hill, A. B., Memory inflation during chronic viral infection is maintained by continuous production of short-lived, functional T cells. Immunity 2008. 29: 650-659.
42. Klarenbeek, P. L., Remmerswaal, E. B., ten Berge, I. J., Doorenspleet, M. E., van Schaik, B. D., Esveldt, R. E., Koch, S. D. et al., Deep sequencing of antiviral T-cell responses to HCMV and EBV in humans reveals a stable repertoire that is maintained for many years. PLoS. Pathog. 2012. 8: e1002889.
43. van de Berg, P. J., Griffiths, S. J., Yong, S. L., Macaulay, R., Bemelman, F. J., Jackson, S., Henson, S. M. et al., Cytomegalovirus infection reduces telomere length of the circulating T cell pool. J. Immunol. 2010. 184: 3417-3423.
44. Henson, S. M., Lanna, A., Riddell, N. E., Franzese, O., Macaulay, R., Griffiths, S. J., Puleston, D. J. et al., p38 signaling inhibits mTORC1-independent autophagy in senescent human CD8(+) T cells. J. Clin. Invest 2014. 124: 4004-4016.
45. Hamann, D., Kostense, S., Wolthers, K. C., Otto, S. A., Baars, P. A., Miedema, F. and van Lier, R. A., Evidence that human CD8+CD45RA+CD27- cells are induced by antigen and evolve through extensive rounds of division. Int. Immunol. 1999. 11: 1027-1033.
46. Hathcock, K. S., Kaech, S. M., Ahmed, R. and Hodes, R. J., Induction of telomerase activity and maintenance of telomere length in virus-specific effector and memory CD8+ T cells. J. Immunol. 2003. 170: 147-152.
47. Weekes, M. P., Wills, M. R., Mynard, K., Hicks, R., Sissons, J. G. and Carmichael, A. J., Large clonal expansions of human virus-specific memory cytotoxic T lymphocytes within the CD57+ CD28- CD8+ T-cell population. Immunology 1999. 98: 443-449.
48. Henson, S. M., Franzese, O., Macaulay, R., Libri, V., Azevedo, R. I., Kiani-Alikhan, S., Plunkett, F. J. et al., KLRG1 signaling induces defective Akt (ser473) phosphorylation and proliferative dysfunction of highly differentiated CD8+ T cells. Blood 2009. 113: 6619-6628.
49. Sallusto, F., Lenig, D., Forster, R., Lipp, M. and Lanzavecchia, A., Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 1999. 401: 708-712.
50. van Leeuwen, E. M., van Buul, J. D., Remmerswaal, E. B., Hordijk, P. L., ten Berge, I. J. and van Lier, R. A., Functional re-expression of CCR7 on CMV-specific CD8+ T cells upon antigenic stimulation. Int. Immunol. 2005. 17: 713-719.
51. Faint, J. M., Annels, N. E., Curnow, S. J., Shields, P., Pilling, D., Hislop, A. D., Wu, L. et al., Memory T cells constitute a subset of the human CD8+CD45RA+ pool with distinct phenotypic and migratory characteristics. J. Immunol. 2001. 167: 212-220.
52. Remmerswaal, E. B., Klarenbeek, P. L., Alves, N. L., Doorenspleet, M. E., van Schaik, B. D., Esveldt, R. E., Idu, M. M. et al., Clonal evolution of CD8+ T cell responses against latent viruses: relationship among phenotype, localization, and function. J. Virol. 2015. 89: 568-580.
53. Letsch, A., Knoedler, M., Na, I. K., Kern, F., Asemissen, A. M., Keilholz, U., Loesch, M. et al., CMV-specific central memory T cells reside in bone marrow. Eur. J. Immunol. 2007. 37: 3063-3068.
54. Sathaliyawala, T., Kubota, M., Yudanin, N., Turner, D., Camp, P., Thome, J. J., Bickham, K. L. et al., Distribution and compartmentalization of human circulating and tissue-resident memory T cell subsets. Immunity 2013. 38: 187-197.
55. Thome, J. J., Yudanin, N., Ohmura, Y., Kubota, M., Grinshpun, B., Sathaliyawala, T., Kato, T. et al., Spatial map of human T cell compartmentalization and maintenance over decades of life. Cell 2014. 159: 814-828.
56. Piet, B., de Bree, G. J., Smids-Dierdorp, B. S., van der Loos, C. M., Remmerswaal, E. B., von der Thusen, J. H., van Haarst, J. M. et al., CD8(+) T cells with an intraepithelial phenotype upregulate cytotoxic function upon influenza infection in human lung. J. Clin. Invest. 2011. 121: 2254-2263.
57. Mackay, L. K., Stock, A. T., Ma, J. Z., Jones, C. M., Kent, S. J., Mueller, S. N., Heath, W. R. et al., Long-lived epithelial immunity by tissue-resident memory T (TRM) cells in the absence of persisting local antigen presentation. Proc. Natl. Acad. Sci. USA 2012. 109: 7037-7042.
58. Jiang, X., Clark, R. A., Liu, L., Wagers, A. J., Fuhlbrigge, R.C. and Kupper, T. S., Skin infection generates non-migratory memory CD8+ T(RM) cells providing global skin immunity. Nature 2012. 483: 227-231.
59. Klonowski, K. D., Williams, K. J., Marzo, A. L., Blair, D. A., Lingenheld, E. G. and Lefrancois, L., Dynamics of blood-borne CD8 memory T cell migration in vivo. Immunity 2004. 20: 551-562.
60. Teijaro, J. R., Turner, D., Pham, Q., Wherry, E. J., Lefrancois, L. and Farber, D. L., Cutting edge: tissue-retentive lung memory CD4 T cells mediate optimal protection to respiratory virus infection. J. Immunol. 2011. 187: 5510-5514.
61. Fish, K. N., Soderberg-Naucler, C., Mills, L. K., Stenglein, S. and Nelson, J. A., Human cytomegalovirus persistently infects aortic endothelial cells. J. Virol. 1998. 72: 5661-5668.
62. van de Berg, P. J., Yong, S. L., Remmerswaal, E. B., van Lier, R. A. and ten Berge, I. J., Cytomegalovirus-induced effector T cells cause endothelial cell damage. Clin. Vaccine Immunol. 2012. 19: 772-779.
63. Imaizumi, T., Yoshida, H. and Satoh, K., Regulation of CX3CL1/fractalkine expression in endothelial cells. J. Atheroscler. Thromb. 2004. 11: 15-21.
64. Bolovan-Fritts, C. A., Trout, R. N. and Spector, S. A., Human cytomegalovirus-specific CD4+-T-cell cytokine response induces fractalkine in endothelial cells. J. Virol. 2004. 78: 13173-13181.
65. Schluns, K. S. and Lefrancois, L., Cytokine control of memory T-cell development and survival. Nat. Rev. Immunol. 2003. 3: 269-279.
66. van Leeuwen, E. M., Gamadia, L. E., Baars, P. A., Remmerswaal, E. B., ten Berge, I. J. and van Lier, R. A., Proliferation requirements of cytomegalovirus-specific, effector-type human CD8+ T cells. J. Immunol. 2002. 169: 5838-5843.
67. Hamann, D., Baars, P. A., Rep, M. H., Hooibrink, B., Kerkhof-Garde, S. R., Klein, M. R. and van Lier, R. A., Phenotypic and functional separation of memory and effector human CD8+ T cells. J. Exp. Med. 1997. 186: 1407-1418.
68. Afonina, I. S., Cullen, S. P. and Martin, S. J., Cytotoxic and non-cytotoxic roles of the CTL/NK protease granzyme B. Immunol. Rev. 2010. 235: 105-116.
69. van Leeuwen, E. M., Remmerswaal, E. B., Vossen, M. T., Rowshani, A. T., Wertheim-van Dillen, P. M., van Lier, R. A. and ten Berge, I. J., Emergence of a CD4+CD28- granzyme B+, cytomegalovirus-specific T cell subset after recovery of primary cytomegalovirus infection. J. Immunol. 2004. 173: 1834-1841.
70. Billiau, A. and Matthys, P., Interferon-gamma: a historical perspective. Cytokine Growth Factor Rev. 2009. 20: 97-113.
71. Raport, C. J., Gosling, J., Schweickart, V. L., Gray, P. W. and Charo, I. F., Molecular cloning and functional characterization of a novel human CC chemokine receptor (CCR5) for RANTES, MIP-1beta, and MIP-1alpha. J. Biol. Chem. 1996. 271: 17161-17166.
72. Cocchi, F., DeVico, A. L., Garzino-Demo, A., Arya, S. K., Gallo, R. C. and Lusso, P., Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells. Science 1995. 270: 1811-1815.
73. Slimani, H., Charnaux, N., Mbemba, E., Saffar, L., Vassy, R., Vita, C. and Gattegno, L., Interaction of RANTES with syndecan-1 and syndecan-4 expressed by human primary macrophages. Biochim. Biophys. Acta 2003. 1617: 80-88.
74. Atemezem, A., Mbemba, E., Vassy, R., Slimani, H., Saffar, L. and Gattegno, L., Human alpha1-acid glycoprotein binds to CCR5 expressed on the plasma membrane of human primary macrophages. Biochem. J. 2001. 356: 121-128.
75. Petrovas, C., Chaon, B., Ambrozak, D. R., Price, D. A., Melenhorst, J. J., Hill, B. J., Geldmacher, C. et al., Differential association of programmed death-1 and CD57 with ex vivo survival of CD8+ T cells in HIV infection. J. Immunol. 2009. 183: 1120-1132.
76. Wherry, E. J., Ha, S. J., Kaech, S. M., Haining, W. N., Sarkar, S., Kalia, V., Subramaniam, S. et al., Molecular signature of CD8+ T cell exhaustion during chronic viral infection. Immunity 2007. 27: 670-684.
77. van der Windt, G. J. and Pearce, E. L., Metabolic switching and fuel choice during T-cell differentiation and memory development. Immunol. Rev. 2012. 249: 27-42.
78. Pearce, E. L., Metabolism in T cell activation and differentiation. Curr. Opin. Immunol. 2010. 22: 314-320.
79. Weinberg, S. E., Sena, L. A. and Chandel, N. S., Mitochondria in the regulation of innate and adaptive immunity. Immunity 2015. 42: 406-417.
80. Chang, C. H., Curtis, J. D., Maggi, L. B., Jr., Faubert, B., Villarino, A. V., O'Sullivan, D., Huang, S. C. et al., Posttranscriptional control of T cell effector function by aerobic glycolysis. Cell 2013. 153: 1239-1251.
81. Gubser, P. M., Bantug, G. R., Razik, L., Fischer, M., Dimeloe, S., Hoenger, G., Durovic, B. et al., Rapid effector function of memory CD8+ T cells requires an immediate-early glycolytic switch. Nat. Immunol. 2013. 14: 1064-1072.
82. van der Windt, G. J., Everts, B., Chang, C. H., Curtis, J. D., Freitas, T. C., Amiel, E., Pearce, E. J. et al., Mitochondrial respiratory capacity is a critical regulator of CD8+ T cell memory development. Immunity 2012. 36: 68-78.
83. van der Windt, G. J., O'Sullivan, D., Everts, B., Huang, S. C., Buck, M. D., Curtis, J. D., Chang, C. H. et al., CD8 memory T cells have a bioenergetic advantage that underlies their rapid recall ability. Proc. Natl. Acad. Sci. USA 2013. 110: 14336-14341.
84. Gamadia, L. E., Remmerswaal, E. B., Weel, J. F., Bemelman, F., van Lier, R.A. and ten Berge, I. J., Primary immune responses to human CMV: a critical role for IFN-gamma-producing CD4+ T cells in protection against CMV disease. Blood 2003. 101: 2686-2692.
85. Jeitziner, S. M., Walton, S. M., Torti, N. and Oxenius, A., Adoptive transfer of cytomegalovirus-specific effector CD4+ T cells provides antiviral protection from murine CMV infection. Eur. J. Immunol. 2013. 43: 2886-2895.
86. Gamadia, L. E., Rentenaar, R. J., van Lier, R. A. and ten Berge, I. J., Properties of CD4(+) T cells in human cytomegalovirus infection. Hum. Immunol. 2004. 65: 486-492.
87. Rentenaar, R. J., Gamadia, L. E., van der Hoek, N., van Diepen, F. N., Boom, R., Weel, J. F., van Lier, R. A. et al., CD4(+) T-cell dynamics in primary cytomegalovirus infection. Transplant. Proc. 2001. 33: 2313-2314.
88. Libri, V., Azevedo, R. I., Jackson, S. E., Di Mitri, M. D., Lachmann, R., Fuhrmann, S., Vukmanovic-Stejic, M. et al., Cytomegalovirus infection induces the accumulation of short-lived, multifunctional CD4+CD45RA+CD27+ T cells: the potential involvement of interleukin-7 in this process. Immunology 2011. 132: 326-339.
89. Di Mitri, M. D., Azevedo, R. I., Henson, S. M., Libri, V., Riddell, N. E., Macaulay, R., Kipling, D. et al., Reversible senescence in human CD4+CD45RA+. J. Immunol. 2011. 187: 2093-2100.
90. Herndler-Brandstetter, D., Landgraf, K., Jenewein, B., Tzankov, A., Brunauer, R., Brunner, S., Parson, W. et al., Human bone marrow hosts polyfunctional memory CD4+ and CD8+ T cells with close contact to IL-15-producing cells. J. Immunol. 2011. 186: 6965-6971.
91. Hegde, N. R., Dunn, C., Lewinsohn, D. M., Jarvis, M. A., Nelson, J. A. and Johnson, D. C., Endogenous human cytomegalovirus gB is presented efficiently by MHC class II molecules to CD4+ CTL. J. Exp. Med. 2005. 202: 1109-1119.
92. van Leeuwen, E. M., Remmerswaal, E. B., Heemskerk, M. H., ten Berge, I. J. and van Lier, R. A., Strong selection of virus-specific cytotoxic CD4+ T-cell clones during primary human cytomegalovirus infection. Blood 2006. 108: 3121-3127.
93. Mason, G. M., Poole, E., Sissons, J. G., Wills, M. R. and Sinclair, J. H., Human cytomegalovirus latency alters the cellular secretome, inducing cluster of differentiation (CD)4+ T-cell migration and suppression of effector function. Proc. Natl. Acad. Sci. USA 2012. 109: 14538-14543.
94. Mason, G. M., Jackson, S., Okecha, G., Poole, E., Sissons, J. G., Sinclair, J. and Wills, M. R., Human cytomegalovirus latency-associated proteins elicit immune-suppressive IL-10 producing CD4(+) T cells. PLoS. Pathog. 2013. 9: e1003635.
95. Quinnan, G. V. and Manischewitz, J. E., The role of natural killer cells and antibody-dependent cell-mediated cytotoxicity during murine cytomegalovirus infection. J. Exp. Med. 1979. 150: 1549-1554.
96. Guma, M., Angulo, A., Vilches, C., Gomez-Lozano, N., Malats, N. and Lopez-Botet, M., Imprint of human cytomegalovirus infection on the NK cell receptor repertoire. Blood 2004. 104: 3664-3671.
97. Lopez-Verges, S., Milush, J. M., Schwartz, B. S., Pando, M. J., Jarjoura, J., York, V. A., Houchins, J. P. et al., Expansion of a unique CD57(+)NKG2Chi natural killer cell subset during acute human cytomegalovirus infection. Proc. Natl. Acad. Sci. USA 2011. 108: 14725-14732.
98. Wu, Z., Sinzger, C., Frascaroli, G., Reichel, J., Bayer, C., Wang, L., Schirmbeck, R. et al., Human cytomegalovirus-induced NKG2C(hi) CD57(hi) natural killer cells are effectors dependent on humoral antiviral immunity. J. Virol. 2013. 87: 7717-7725.
99. Beziat, V., Dalgard, O., Asselah, T., Halfon, P., Bedossa, P., Boudifa, A., Hervier, B. et al., CMV drives clonal expansion of NKG2C+ NK cells expressing self-specific KIRs in chronic hepatitis patients. Eur. J. Immunol. 2012. 42: 447-457.
100. Foley, B., Cooley, S., Verneris, M. R., Pitt, M., Curtsinger, J., Luo, X., Lopez-Verges, S. et al., Cytomegalovirus reactivation after allogeneic transplantation promotes a lasting increase in educated NKG2C+ natural killer cells with potent function. Blood 2012. 119: 2665-2674.
101. Foley, B., Cooley, S., Verneris, M. R., Curtsinger, J., Luo, X., Waller, E. K., Anasetti, C. et al., Human cytomegalovirus (CMV)-induced memory-like NKG2C(+) NK cells are transplantable and expand in vivo in response to recipient CMV antigen. J. Immunol. 2012. 189: 5082-5088.
102. Muntasell, A., Lopez-Montanes, M., Vera, A., Heredia, G., Romo, N., Penafiel, J., Moraru, M. et al., NKG2C zygosity influences CD94/NKG2C receptor function and the NK-cell compartment redistribution in response to human cytomegalovirus. Eur. J. Immunol. 2013. 43: 3268-3278.
103. Lanier, L. L., NK cell recognition. Annu. Rev. Immunol. 2005. 23: 225-274.
104. Tomasec, P., Braud, V. M., Rickards, C., Powell, M. B., McSharry, B. P., Gadola, S., Cerundolo, V. et al., Surface expression of HLA-E, an inhibitor of natural killer cells, enhanced by human cytomegalovirus gpUL40. Science 2000. 287: 1031.
105. Muntasell, A., Vilches, C., Angulo, A. and Lopez-Botet, M., Adaptive reconfiguration of the human NK-cell compartment in response to cytomegalovirus: a different perspective of the host-pathogen interaction. Eur. J. Immunol. 2013. 43: 1133-1141.
106. Beziat, V., Liu, L. L., Malmberg, J. A., Ivarsson, M. A., Sohlberg, E., Bjorklund, A. T., Retiere, C. et al., NK cell responses to cytomegalovirus infection lead to stable imprints in the human KIR repertoire and involve activating KIRs. Blood 2013. 121: 2678-2688.
107. Guma, M., Budt, M., Saez, A., Brckalo, T., Hengel, H., Angulo, A. and Lopez-Botet, M., Expansion of CD94/NKG2C+ NK cells in response to human cytomegalovirus-infected fibroblasts. Blood 2006. 107: 3624-3631.
108. Sun, J. C., Beilke, J. N. and Lanier, L. L., Adaptive immune features of natural killer cells. Nature 2009. 457: 557-561.
109. Petitdemange, C., Becquart, P., Wauquier, N., Beziat, V., Debre, P., Leroy, E. M. and Vieillard, V., Unconventional repertoire profile is imprinted during acute chikungunya infection for natural killer cells polarization toward cytotoxicity. PLoS Pathog. 2011. 7: e1002268.
110. Guma, M., Cabrera, C., Erkizia, I., Bofill, M., Clotet, B., Ruiz, L. and Lopez-Botet, M., Human cytomegalovirus infection is associated with increased proportions of NK cells that express the CD94/NKG2C receptor in aviremic HIV-1-positive patients. J. Infect. Dis. 2006. 194: 38-41.
111. Bjorkstrom, N. K., Lindgren, T., Stoltz, M., Fauriat, C., Braun, M., Evander, M., Michaelsson, J. et al., Rapid expansion and long-term persistence of elevated NK cell numbers in humans infected with hantavirus. J. Exp. Med. 2011. 208: 13-21.
112. Luetke-Eversloh, M., Hammer, Q., Durek, P., Nordstrom, K., Gasparoni, G., Pink, M., Hamann, A. et al., Human cytomegalovirus drives epigenetic imprinting of the IFNG locus in NKG2Chi natural killer cells. PLoS Pathog. 2014. 10: e1004441.
113. Karre, K., Ljunggren, H. G., Piontek, G. and Kiessling, R., Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy. Nature 1986. 319: 675-678.
114. Joshi, N. S., Cui, W., Chandele, A., Lee, H. K., Urso, D. R., Hagman, J., Gapin, L. et al., Inflammation directs memory precursor and short-lived effector CD8(+) T cell fates via the graded expression of T-bet transcription factor. Immunity 2007. 27: 281-295.
115. Rutishauser, R. L., Martins, G. A., Kalachikov, S., Chandele, A., Parish, I. A., Meffre, E., Jacob, J.et al., Transcriptional repressor Blimp-1 promotes CD8(+) T cell terminal differentiation and represses the acquisition of central memory T cell properties. Immunity 2009. 31: 296-308.
116. Kallies, A., Xin, A., Belz, G. T. and Nutt, S. L., Blimp-1 transcription factor is required for the differentiation of effector CD8(+) T cells and memory responses. Immunity 2009. 31: 283-295.
117. Banerjee, A., Gordon, S. M., Intlekofer, A. M., Paley, M. A., Mooney, E. C., Lindsten, T., Wherry, E. J. et al., Cutting edge: the transcription factor eomesodermin enables CD8+ T cells to compete for the memory cell niche. J. Immunol. 2010. 185: 4988-4992.
118. Pearce, E. L., Mullen, A. C., Martins, G. A., Krawczyk, C. M., Hutchins, A. S., Zediak, V. P., Banica, M. et al., Control of effector CD8+ T cell function by the transcription factor Eomesodermin. Science 2003. 302: 1041-1043.
119. Intlekofer, A. M., Takemoto, N., Wherry, E. J., Longworth, S. A., Northrup, J. T., Palanivel, V. R., Mullen, A. C. et al., Effector and memory CD8+ T cell fate coupled by T-bet and eomesodermin. Nat. Immunol. 2005. 6: 1236-1244.
120. Knox, J. J., Cosma, G. L., Betts, M. R. and McLane, L. M., Characterization of T-bet and eomes in peripheral human immune cells. Front Immunol. 2014. 5: 217.
121. van Aalderen, M. C., Remmerswaal, E. B., Verstegen, N. J., Hombrink, P., Ten, B. A., Pircher, H., Kootstra, N. A. et al., Infection history determines the differentiation state of human CD8+ T cells. J. Virol. 2015. 89: 5110-5123.
122. Buggert, M., Tauriainen, J., Yamamoto, T., Frederiksen, J., Ivarsson, M. A., Michaelsson, J., Lund, O. et al., T-bet and Eomes are differentially linked to the exhausted phenotype of CD8+ T cells in HIV infection. PLoS Pathog. 2014. 10: e1004251.
123. Paley, M. A., Kroy, D. C., Odorizzi, P. M., Johnnidis, J. B., Dolfi, D. V., Barnett, B. E., Bikoff, E. K.et al., Progenitor and terminal subsets of CD8+ T cells cooperate to contain chronic viral infection. Science 2012. 338: 1220-1225.
124. Popescu, I., Pipeling, M. R., Shah, P. D., Orens, J. B. and McDyer, J. F., T-bet:Eomes balance, effector function, and proliferation of cytomegalovirus-specific CD8+ T cells during primary infection differentiates the capacity for durable immune control. J. Immunol. 2014. 193: 5709-5722.
125. Beaulieu, A. M., Zawislak, C. L., Nakayama, T. and Sun, J. C., The transcription factor Zbtb32 controls the proliferative burst of virus-specific natural killer cells responding to infection. Nat. Immunol. 2014. 15: 546-553.
126. Kallies, A., Carotta, S., Huntington, N. D., Bernard, N. J., Tarlinton, D. M., Smyth, M. J. and Nutt, S. L., A role for Blimp1 in the transcriptional network controlling natural killer cell maturation. Blood 2011. 117: 1869-1879.
127. Smith, M. A., Maurin, M., Cho, H. I., Becknell, B., Freud, A. G., Yu, J., Wei, S. et al., PRDM1/Blimp-1 controls effector cytokine production in human NK cells. J. Immunol. 2010. 185: 6058-6067.
128. van Gisbergen, K. P., Kragten, N. A., Hertoghs, K. M., Wensveen, F. M., Jonjic, S., Hamann, J., Nolte, M. A. et al., Mouse Hobit is a homolog of the transcriptional repressor Blimp-1 that regulates NKT cell effector differentiation. Nat. Immunol. 2012. 13: 864-871.
129. Vieira Braga, F. A., Hertoghs, K. M. L., Kragten, N. A., Doody, G. M., Barnes, N. A., Remmerswaal, E. B., Hsiao, C. C. et al., The Blimp-1 homologue Hobit identifies effector-type lymphocytes in humans. Eur. J. Immunol. 2015, in press DOI: 10.1002/eji.201545650.